22:40:55 EDT Fri 30 Sep 2022
Enter Symbol
or Name
USA
CA



Highmark Interactive Inc
Symbol HMRK
Shares Issued 40,032,808
Close 2022-08-12 C$ 0.09
Recent Sedar Documents

Highmark Interactive issues $1-million convertible note

2022-08-12 16:23 ET - News Release

Dr. Sanjeev Sharma reports

HIGHMARK INTERACTIVE INC. ISSUES $1 MILLION CONVERTIBLE NOTE FOR WORKING CAPITAL & GROWTH

Highmark Interactive Inc. has issued a $1-million 8 per cent convertible note paid semi-annually for a term of two years with a conversion price based on future equity issuance. Purchasers of the note are management and directors. The price at which the note may be converted will not be less than the greater of (i) nine cents and (ii) the offering price of an equity financing in year one of the note and (i) 10 cents and (ii) the offering price of an equity financing in year two of the note.

The funds will be used for the purposes of working capital to expedite sales and marketing initiatives for the ER (emergency room) Think Ahead Pathways program, ER deployment, and to assist in the continued expansion of Highmark's Food and Drug Administration-approved EQ software into the U.S. marketplace.

About Highmark Interactive Inc.

Highmark Interactive was created to change the paradigm of testing and management for brain and mental health. Highmark's approach is focused on providing real-time data to health providers to support pro-active, preventative interventions and targeted care planning to improve health outcomes.

In addition to a growing network of virtual, in-person and hybrid clinics, Highmark Interactive offers the world's first gamified, FDA-cleared patient-led assessments as well as digital clinician-led assessments of neurofunction and balance. Together, the technology is used in more than 350 health organizations globally.

By unlocking insights, Highmark's platform enables precision medicine and creates a more contemporary model for delivering better outcomes in medical, mental health and rehabilitation services.

© 2022 Canjex Publishing Ltd. All rights reserved.